Sorry, it was a reference in an article in the NYT of today mentioning that in the USA no new studies will be allowed that focus on treating the sickest patients.
This is the article of today, which nevertheless may be important:
Coronavirus Attacks the Lungs. A Federal Agency Just Halted Funding for New Lung Treatments.The shift, quietly disclosed on a government website, highlights how the Trump administration is favoring development of vaccines over treatments for the sickest patients.
https://www.nytimes.com/2020/06/19/health/coronavirus-lung-treatment-funding.html?campaign_id=2&emc=edit_th_20200622&instance_id=19597&nl=todaysheadlines®i_id=47137258&segment_id=31520&user_id=59de3a816b3f8c4bddb5f038ebde0ca4
And here is the passage where the study of mesoblast (april indeed) is referred to:
Researchers and companies are also testing stem cell therapies, which are also believed to dampen the immune system.One company, Mesoblast, is testing its stem cell product in patients with severe Covid-19 as part of a clinical trial supported by an arm of the National Institutes of Health.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
-0.005(0.30%) |
Mkt cap ! $2.082B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.66 | $1.63 | $796.7K | 485.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 32327 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 43655 | 12 |
View Market Depth
| Last trade - 11.04am 14/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |